US619455A
(en)
|
|
1899-02-14 |
|
Steaming vessel |
BE666904A
(fr)
|
1964-07-14 |
|
|
|
GB1219606A
(en)
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
EP0147716A3
(fr)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Procédé et dispositif pour la transmission chiffrable d'une suite de signaux binaires d'information avec contrôle d'authenticité
|
EP0154316B1
(fr)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Lymphokine chimiquement modifiée et son procédé de préparation
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
DE3856559T2
(de)
|
1987-05-21 |
2004-04-29 |
Micromet Ag |
Multifunktionelle Proteine mit vorbestimmter Zielsetzung
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
ATE135370T1
(de)
|
1988-12-22 |
1996-03-15 |
Kirin Amgen Inc |
Chemisch modifizierte granulocytenkolonie erregender faktor
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
GB8916480D0
(en)
|
1989-07-19 |
1989-09-06 |
Glaxo Group Ltd |
Chemical process
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
EP0814159B1
(fr)
|
1990-08-29 |
2005-07-27 |
GenPharm International, Inc. |
Souris transgéniques capables de produire des anticorps hétérologues
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
WO1994025585A1
(fr)
|
1993-04-26 |
1994-11-10 |
Genpharm International, Inc. |
Animaux transgeniques capables de produire des anticorps heterologues
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
PT100441A
(pt)
|
1991-05-02 |
1993-09-30 |
Smithkline Beecham Corp |
Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
|
US5451700A
(en)
|
1991-06-11 |
1995-09-19 |
Ciba-Geigy Corporation |
Amidino compounds, their manufacture and methods of treatment
|
JPH0525045A
(ja)
|
1991-07-18 |
1993-02-02 |
Tanabe Seiyaku Co Ltd |
経皮吸収製剤
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
CA2124967C
(fr)
|
1991-12-17 |
2008-04-08 |
Nils Lonberg |
Animaux transgeniques non humains capables de produire des anticorps heterologues
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
WO1993018007A1
(fr)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Nouveau derive de carbostyrile
|
US5605923A
(en)
|
1992-04-02 |
1997-02-25 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
US5552438A
(en)
|
1992-04-02 |
1996-09-03 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
WO1993019750A1
(fr)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Composes efficaces dans le traitement de maladies allergiques ou inflammatoires
|
WO1993022332A2
(fr)
|
1992-04-24 |
1993-11-11 |
Board Of Regents, The University Of Texas System |
Production recombinante de domaines semblables a l'immunoglobuline dans des cellules procaryotes
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
AU5010793A
(en)
|
1992-08-21 |
1994-03-15 |
Schering Corporation |
Human interleukin-13
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
WO1994029351A2
(fr)
|
1993-06-16 |
1994-12-22 |
Celltech Limited |
Anticorps
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
GB9414193D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
GB9414208D0
(en)
|
1994-07-14 |
1994-08-31 |
Glaxo Group Ltd |
Compounds
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
GB9622386D0
(en)
|
1996-10-28 |
1997-01-08 |
Sandoz Ltd |
Organic compounds
|
TW528755B
(en)
|
1996-12-24 |
2003-04-21 |
Glaxo Group Ltd |
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
DE69833755T2
(de)
|
1997-05-21 |
2006-12-28 |
Biovation Ltd. |
Verfahren zur herstellung von nicht-immunogenen proteinen
|
US6166037A
(en)
|
1997-08-28 |
2000-12-26 |
Merck & Co., Inc. |
Pyrrolidine and piperidine modulators of chemokine receptor activity
|
WO1999016766A1
(fr)
|
1997-10-01 |
1999-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Derives de benzodioxole
|
GB9723566D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723590D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
GB9723589D0
(en)
|
1997-11-08 |
1998-01-07 |
Glaxo Group Ltd |
Chemical compounds
|
YU44900A
(sh)
|
1998-01-31 |
2003-01-31 |
Glaxo Group Limited |
Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
|
CO4990969A1
(es)
|
1998-02-14 |
2000-12-26 |
Glaxo Group Ltd |
Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
ES2340112T3
(es)
|
1998-04-20 |
2010-05-28 |
Glycart Biotechnology Ag |
Ingenieria de glicosilacion de anticuerpos para la mejora de la citotoxicidad celular dependiente de anticuerpos.
|
US6541669B1
(en)
|
1998-06-08 |
2003-04-01 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9813540D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
KR20010071591A
(ko)
|
1998-06-23 |
2001-07-28 |
그레이엄 브레레톤, 레슬리 에드워즈 |
2-(퓨린-9-일)-테트라히드로푸란-3,4-디올 유도체
|
GB9813565D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
GB9813535D0
(en)
|
1998-06-23 |
1998-08-19 |
Glaxo Group Ltd |
Chemical compounds
|
WO2000000531A1
(fr)
|
1998-06-30 |
2000-01-06 |
The Dow Chemical Company |
Polymeres et leur procede de production
|
WO2000023457A1
(fr)
|
1998-10-16 |
2000-04-27 |
Pfizer Limited |
Derives d'adenine
|
CN104611339A
(zh)
|
1998-12-14 |
2015-05-13 |
遗传研究所有限责任公司 |
细胞因子受体链
|
PL209786B1
(pl)
|
1999-01-15 |
2011-10-31 |
Genentech Inc |
Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
|
AU2750800A
(en)
|
1999-02-01 |
2000-08-18 |
Amgen Canada Inc. |
Materials and methods to inhibit hodgkin and reed sternberg cell growth
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
CA2704600C
(fr)
|
1999-04-09 |
2016-10-25 |
Kyowa Hakko Kirin Co., Ltd. |
Methode de production d'anticorps avec activite adcc accrue
|
CZ20013940A3
(cs)
|
1999-05-04 |
2002-04-17 |
Schering Corporation |
Piperazinové deriváty uľitečné jako CCR5 antagonisté
|
RU2266281C2
(ru)
|
1999-05-04 |
2005-12-20 |
Шеринг Корпорейшн |
Производные пиперидина, фармацевтическая композиция на их основе и способ лечения инфекции вирусом hiv
|
YU25500A
(sh)
|
1999-05-11 |
2003-08-29 |
Pfizer Products Inc. |
Postupak za sintezu analoga nukleozida
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
GB9913932D0
(en)
|
1999-06-15 |
1999-08-18 |
Pfizer Ltd |
Purine derivatives
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
DE60037896D1
(de)
|
1999-07-29 |
2008-03-13 |
Medarex Inc |
Menschliche antikörper gegen her2/neu
|
SI1212089T1
(sl)
|
1999-08-21 |
2006-08-31 |
Altana Pharma Ag |
Sinergisticna kombinacija roflumilasta in salmeterola
|
KR100942863B1
(ko)
|
1999-08-24 |
2010-02-17 |
메다렉스, 인코포레이티드 |
인간 씨티엘에이-4 항체 및 그의 용도
|
CO5180581A1
(es)
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
US6794132B2
(en)
|
1999-10-02 |
2004-09-21 |
Biosite, Inc. |
Human antibodies
|
GB9924361D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Ltd |
Purine derivatives
|
GB9924363D0
(en)
|
1999-10-14 |
1999-12-15 |
Pfizer Central Res |
Purine derivatives
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
US6645486B1
(en)
|
2000-01-25 |
2003-11-11 |
Ludwig Institute For Cancer Research |
Method of treatment with IL-9 conjugate
|
GB0003960D0
(en)
|
2000-02-18 |
2000-04-12 |
Pfizer Ltd |
Purine derivatives
|
GB0004016D0
(en)
|
2000-02-22 |
2000-04-12 |
Royal Brompton Hospital |
Biological material and uses thereof
|
HUP0300832A2
(hu)
|
2000-04-27 |
2003-08-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
TWI227240B
(en)
|
2000-06-06 |
2005-02-01 |
Pfizer |
2-aminocarbonyl-9H-purine derivatives
|
GB0015727D0
(en)
|
2000-06-27 |
2000-08-16 |
Pfizer Ltd |
Purine derivatives
|
HU229306B1
(en)
|
2000-06-27 |
2013-10-28 |
L V A T Lab Sa |
Carbamates derived from arylalkylamines
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
CA2417825C
(fr)
|
2000-08-05 |
2008-07-22 |
Glaxo Group Limited |
6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyle) oxy!-11.beta.-hydroxy-16.alpha.-methyle-3-oxo-androst-1,4,-diene-17-acide carbothioique s-fluoromethyle ester utilise comme agent anti inflammatoire
|
GB0022695D0
(en)
|
2000-09-15 |
2000-11-01 |
Pfizer Ltd |
Purine Derivatives
|
GB0028383D0
(en)
|
2000-11-21 |
2001-01-03 |
Novartis Ag |
Organic compounds
|
JP3523245B1
(ja)
|
2000-11-30 |
2004-04-26 |
メダレックス,インコーポレーテッド |
ヒト抗体作製用トランスジェニック染色体導入齧歯動物
|
KR100869722B1
(ko)
|
2000-12-22 |
2008-11-21 |
알미랄 에이쥐 |
퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용
|
ATE334128T1
(de)
|
2000-12-28 |
2006-08-15 |
Almirall Prodesfarma Ag |
Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
WO2002070490A1
(fr)
|
2001-03-08 |
2002-09-12 |
Glaxo Group Limited |
Agonistes de beta-adrenocepteurs
|
EP1241176A1
(fr)
|
2001-03-16 |
2002-09-18 |
Pfizer Products Inc. |
Dérivés de purine pour le traitement de l'ischémie
|
DE60224172T2
(de)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Formanilid-derivative als beta2-adrenorezeptor-agonisten
|
US7291608B2
(en)
|
2001-04-30 |
2007-11-06 |
Glaxo Group Limited |
Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
|
WO2002092780A2
(fr)
|
2001-05-17 |
2002-11-21 |
Diversa Corporation |
Nouvelles molecules de liaison a un antigene destinees a des applications therapeutiques, diagnostiques, prophylactiques, enzymatiques, industrielles et agricoles et procedes de generation et de criblage de telles molecules
|
MXPA03010787A
(es)
|
2001-05-25 |
2004-03-02 |
Pfizer |
Un agonista del receptor a2a de adenosina en combinacion con un agente anticolinergico para el tratamiento de enfermedades obstructivas de las vias aereas.
|
US20040248867A1
(en)
|
2001-06-12 |
2004-12-09 |
Keith Biggadike |
Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
|
DE10129392A1
(de)
|
2001-06-20 |
2003-01-02 |
Convenience Food Sys Wallau |
Werkzeug mit einem Sensorchip
|
EP2327766B1
(fr)
|
2001-06-21 |
2015-12-02 |
BASF Enzymes LLC |
Nitralases
|
WO2003007685A2
(fr)
|
2001-07-17 |
2003-01-30 |
University Of Florida |
Detection et traitement de troubles de l'appareil genital
|
DK1425001T3
(da)
|
2001-09-14 |
2009-04-14 |
Glaxo Group Ltd |
Phenethanolaminderivater til behandling af respiratoriske sygdomme
|
AU2002334969A1
(en)
|
2001-10-09 |
2003-04-22 |
Sylvie Barchechath |
Use of stat-6 inhibitors as therapeutic agents
|
EP1438309A1
(fr)
|
2001-10-17 |
2004-07-21 |
Ucb, S.A. |
Derives de quinuclidine, leurs procedes de preparation, et leurs utilisations en tant qu'inhibiteurs de recepteur muscarinique m2 et/ou m3
|
WO2003034984A2
(fr)
|
2001-10-19 |
2003-05-01 |
Genentech, Inc. |
Compositions et procedes pour le diagnostic et le traitement d'affections intestinales inflammatoires
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
MXPA04003798A
(es)
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
US20040248260A1
(en)
|
2001-10-26 |
2004-12-09 |
Heavner George A. |
IL-13 mutein proteins, antibodies, compositions, methods and uses
|
EP1578912A4
(fr)
|
2001-10-26 |
2007-12-26 |
Centocor Inc |
Proteines muteines il-13, anticorps, compositions, procedes et utilisations
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
WO2003042160A1
(fr)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Agonistes de recepteur d'aryl aniline beta-2 adrenergique
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
WO2003048181A1
(fr)
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha.-esters cycliques de 16-methylpregnan-3,20-dione en tant qu'agents anti-inflammatoires
|
EP1461336B1
(fr)
|
2001-12-20 |
2013-05-22 |
CHIESI FARMACEUTICI S.p.A. |
Derives de 1-alkyl-1- azoniabicyclo (2.2.2) octane carbamate et leur utilisation comme antagonistes du recepteur muscarinique
|
AU2003202044A1
(en)
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
US20040110226A1
(en)
|
2002-03-01 |
2004-06-10 |
Xencor |
Antibody optimization
|
CA2477764A1
(fr)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Mimetiques du glucocorticoide, procedes de fabrication de ces mimetiques, compositions pharmaceutiques et leurs utilisations
|
MXPA04009329A
(es)
|
2002-03-26 |
2005-01-25 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos.
|
AU2003223497A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Centocor, Inc. |
Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
|
US20090170803A1
(en)
|
2002-04-10 |
2009-07-02 |
Linden Joel M |
Adjunctive treatment of biological diseases
|
DE60335869D1
(de)
|
2002-04-11 |
2011-03-10 |
Merck Sharp & Dohme |
1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
|
ES2206021B1
(es)
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
JP2005523920A
(ja)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
フェネタノールアミン誘導体
|
AU2003243189B2
(en)
|
2002-05-01 |
2008-01-24 |
Regeneron Pharmaceuticals, Inc. |
Methods of using cytokine antagonists to treat HIV infection and AIDS
|
EP1507754A1
(fr)
|
2002-05-28 |
2005-02-23 |
Theravance, Inc. |
Agonistes du recepteur adrenergique beta 2 alcoxy aryle
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
ES2201907B1
(es)
|
2002-05-29 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
|
JP4753578B2
(ja)
|
2002-06-03 |
2011-08-24 |
ジェネンテック, インコーポレイテッド |
合成抗体ファージライブラリー
|
DE10224888A1
(de)
|
2002-06-05 |
2003-12-24 |
Merck Patent Gmbh |
Pyridazinderivate
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
DE10227269A1
(de)
|
2002-06-19 |
2004-01-08 |
Merck Patent Gmbh |
Thiazolderivate
|
ES2282667T3
(es)
|
2002-06-25 |
2007-10-16 |
Merck Frosst Canada Ltd. |
Inhibidores de pde4 8-(biaril)quinolinas.
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
EP1519922A1
(fr)
|
2002-07-02 |
2005-04-06 |
Merck Frosst Canada & Co. |
Ethane pyridone a substitution diaryle, inhibiteurs d'enzyme pde4
|
ES2518940T3
(es)
|
2002-07-08 |
2014-11-06 |
Pfizer Products Inc. |
Moduladores del receptor de glucocorticoides
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(es)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
|
US20060166995A1
(en)
|
2002-08-10 |
2006-07-27 |
Altana Pharma Ag |
Piperidine-n-oxide-derivatives
|
WO2004018449A1
(fr)
|
2002-08-10 |
2004-03-04 |
Altana Pharma Ag |
Derives de piperidine utilises comme inhibiteurs de la phospodiesterase-4 (pde4)
|
AU2003258576B2
(en)
|
2002-08-10 |
2009-07-30 |
Takeda Gmbh |
Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
|
US20060167001A1
(en)
|
2002-08-10 |
2006-07-27 |
Sterk Jan G |
Pyridazinone-derivatives as pde4 inhibitors
|
EP1581533A2
(fr)
|
2002-08-17 |
2005-10-05 |
ALTANA Pharma AG |
Nouvelles benzonaphtyridines
|
JP2005537312A
(ja)
|
2002-08-17 |
2005-12-08 |
アルタナ ファルマ アクチエンゲゼルシャフト |
新規のフェナントリジン
|
SE0202483D0
(sv)
|
2002-08-21 |
2002-08-21 |
Astrazeneca Ab |
Chemical compounds
|
DE60322713D1
(de)
|
2002-08-21 |
2008-09-18 |
Boehringer Ingelheim Pharma |
Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
|
US7288562B2
(en)
|
2002-08-23 |
2007-10-30 |
Ranbaxy Laboratories Limited |
Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
|
DE60311662T2
(de)
|
2002-08-29 |
2007-10-25 |
Altana Pharma Ag |
3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
|
ATE473740T1
(de)
|
2002-08-29 |
2010-07-15 |
Boehringer Ingelheim Pharma |
3-(sulfonamidoethyl)-indol-derivate zur verwendung als glucocorticoid-mimetika bei der behandlung von entzündlichen, allergischen und proliferativen erkrankungen
|
ATE348616T1
(de)
|
2002-08-29 |
2007-01-15 |
Altana Pharma Ag |
2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
RU2005111225A
(ru)
|
2002-09-18 |
2005-08-27 |
Оно Фармасьютикал Ко., Лтд. (Jp) |
Производные триазаспиро[5.5]ундекана и лекарственные средства, содержащие их в качестве активного ингредиента
|
JP2006096662A
(ja)
|
2002-09-18 |
2006-04-13 |
Sumitomo Pharmaceut Co Ltd |
新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
JP2004107299A
(ja)
|
2002-09-20 |
2004-04-08 |
Japan Energy Corp |
新規1−置換ウラシル誘導体及びアレルギー性疾患の治療剤
|
WO2004026248A2
(fr)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Derives d'octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide en tant que modulateurs selectifs de recepteur glucocorticoide
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
EP1440966A1
(fr)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Dérivés d'indole utilisables pour traiter des maladies
|
CA2499314C
(fr)
|
2002-10-11 |
2010-08-24 |
Pfizer Inc. |
Derives d'indole utilises comme agonistes beta-2
|
ES2291733T3
(es)
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
JP2006506379A
(ja)
|
2002-10-23 |
2006-02-23 |
グレンマーク・ファーマシューティカルズ・リミテッド |
炎症性およびアレルギー性疾患の治療に有用な新規三環式化合物:その調製方法およびそれらを含む医薬組成物
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR041724A1
(es)
|
2002-10-28 |
2005-05-26 |
Glaxo Group Ltd |
Compuestos derivados de fenetanolamina y su utilizacion en composiciones farmaceuticas
|
GB0225287D0
(en)
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10253426B4
(de)
|
2002-11-15 |
2005-09-22 |
Elbion Ag |
Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
EP1578947A4
(fr)
*
|
2002-12-02 |
2006-12-06 |
Abgenix Inc |
Anticorps diriges contre la phospholipase a2 et utilisations
|
DE10261874A1
(de)
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
JP4606408B2
(ja)
|
2003-01-21 |
2011-01-05 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的グルココルチコイド受容体調節物質としての17−カルバモイルオキシコルチゾル誘導体
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
EP1460064A1
(fr)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Derivés de Indole-2-carboxamide comme beta-2 agonistes
|
US20040242841A1
(en)
|
2003-03-18 |
2004-12-02 |
Cammack J. Kevin |
Methods for extending amorphous photorefractive material lifetimes
|
WO2004089892A2
(fr)
|
2003-04-01 |
2004-10-21 |
Theravance, Inc. |
Diarylmethyle et composes apparentes
|
ATE421322T1
(de)
|
2003-04-04 |
2009-02-15 |
Novartis Pharma Gmbh |
Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
JP4616264B2
(ja)
|
2003-05-28 |
2011-01-19 |
セラヴァンス, インコーポレーテッド |
ムスカリン性レセプターアンタゴニストとしてのアザビシクロアルカン化合物
|
ES2298757T3
(es)
|
2003-06-04 |
2008-05-16 |
Pfizer Inc. |
Derivados de z-amino-piridina como agonistas de adrecorreceptores beta-2.
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
WO2005033121A2
(fr)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthese de 2-aralkyloxyadenosines, 2-alkoxyadenosines, et leurs analogues
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
HUE049161T2
(hu)
|
2003-12-23 |
2020-09-28 |
Genentech Inc |
Új anti-IL13 antitestek és alkalmazásaik
|
CA2557724A1
(fr)
|
2004-02-27 |
2005-10-06 |
Centocor, Inc. |
Procedes et compositions pour traiter des pathologies associees a l'il-13
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
US20070048785A1
(en)
|
2004-06-09 |
2007-03-01 |
Lin Laura L |
Anti-IL-13 antibodies and complexes
|
AR049390A1
(es)
*
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
US7563443B2
(en)
*
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
MX2007005866A
(es)
*
|
2004-11-17 |
2007-11-12 |
Amgen Inc |
Anticuerpos monoclonales totalmente humanos para il-13.
|
US20080044420A1
(en)
*
|
2005-05-11 |
2008-02-21 |
Heavner George A |
Anti-IL-13 antibodies, compositions, methods and uses
|
WO2007041219A2
(fr)
|
2005-09-30 |
2007-04-12 |
Centocor, Inc. |
Compositions et methodes pour des biomarqueurs pour il-13
|
US20080248048A1
(en)
|
2005-09-30 |
2008-10-09 |
Astrazeneca Ab |
Interleukin-13 Antibody Composition
|
CA2625664C
(fr)
*
|
2005-10-21 |
2016-01-05 |
Novartis Ag |
Molecules organiques
|
AU2006330858A1
(en)
|
2005-12-21 |
2007-07-05 |
Wyeth |
Protein formulations with reduced viscosity and uses thereof
|
GB0600488D0
(en)
|
2006-01-11 |
2006-02-22 |
Glaxo Group Ltd |
Immunoglobulins
|
WO2007085815A2
(fr)
|
2006-01-24 |
2007-08-02 |
Domantis Limited |
Ligands qui lient il-4 et/ou il-13
|
CN103458927A
(zh)
*
|
2011-02-17 |
2013-12-18 |
诺华股份有限公司 |
瘘管型克罗恩病的治疗
|